Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin to Reduce Mucositis in Autologous Transplant
NCT04896164Phase 3Unknown
- Sponsor
- Tata Memorial Centre
- Start
- Dec 2018
- Primary completion
- May 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of curcumin in oral mucositis (OM), sponsored by Tata Memorial Centre. Status: unknown.
02
Drugs
curcumin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT04896164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04896164.